Company
AERSKA
RNA medicines to treat, delay, and prevent diseases of the brain
Also known as Aerska Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Aerska Inc.
- aerska.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Targeted delivery of RNA medicines to the brain. By silencing the genes that cause harm, we aim to preserve minds, protect memories, and enable our loved ones to live healthier, longer lives.
Funding snapshot
- Total raised
- $60MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $39M2026-02-09
Funding rounds
- Series A
- $39M2026-02-09, Company stated
- Seed
- $21M2025-10-01, Company stated
Loading relationship preview